EGF drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (13)
Papers in which this entity is mentioned.
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Massively parallel reporter assay investigates shared genetic variants of eight psychiatric disorders. (2025)
- Human 3D brain organoids: steering the demolecularization of brain and neurological diseases. (2023)
- Programmed suppression of oxidative phosphorylation and mitochondrial function by gestational alcohol exposure correlate with widespread increases in H3K9me2 that do not suppress transcription. (2021)
- Macrophage Polarization States in the Tumor Microenvironment. (2021)
- AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications. (2020)
- Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencing. (2020)
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. (2017)
- Fragment Length of Circulating Tumor DNA. (2016)
- Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
- PVT1 dependence in cancer with MYC copy-number increase. (2014)
- Cancer genome landscapes. (2013)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| egf | drug | 41 | 82 |